TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
BMY

Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General

58.80$ -3.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Bristol-Myers Squibb Company (BMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 12,973 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BMY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
4,922 5,243 4,929 5,144 5,254 5,449 5,193 5,704 5,691 5,973 5,920 6,273 6,007 7,945 10,781 10,129 10,540 11,068 11,073 11,703 11,624 11,985 11,648 11,887 11,218 11,406 11,337 11,226 10,966 11,477 11,865 12,201 11,892 12,342 11,201 12,269 12,222 12,503 11,489 12,973 49,187
1,305 1,571 1,219 1,387 1,564 1,693 1,591 1,598 1,649 1,688 1,832 1,870 1,788 3,530 5,931 5,080 4,978 4,829 4,985 4,992 4,855 4,792 4,888 5,094 4,771 4,916 4,821 5,097 4,746 4,985 5,275 5,400 5,275 4,918 3,033 3,372 3,435 4,097 3,421 3,726 14,679
3,617 3,672 3,710 3,757 3,690 3,756 3,602 4,106 4,042 4,285 4,088 4,403 4,219 4,415 4,850 5,049 5,562 6,239 6,088 6,711 6,769 7,193 6,760 6,793 6,447 6,490 6,516 6,129 6,220 6,492 6,590 6,801 6,617 7,424 8,168 8,897 8,787 8,406 8,068 9,247 34,508
1,138 1,214 1,021 1,088 1,479 1,411 1,230 2,416 1,262 1,358 1,300 1,309 1,362 1,988 2,316 2,483 2,496 2,790 2,224 3,271 3,250 2,607 2,220 2,321 2,360 2,510 2,301 2,258 2,178 2,476 2,694 2,295 2,353 2,788 2,257 2,580 2,528 2,586 2,649 2,959 10,722
19 25 33 36 22 71 980 1,131 1,104 1,336 1,006 1,076 1,055 1,734 1,606 1,628 1,706 2,721 1,666 1,882 1,787 1,042 1,831 1,787 1,930 2,266 1,762 1,934 1,938 664 2,367 1,928 1,983 352 1,584 1,713 1,789 2,181 1,617 1,826 7,413
2,282 2,675 2,095 2,255 2,626 2,727 2,209 3,547 2,365 2,695 2,305 2,385 2,417 3,714 3,922 4,110 4,196 5,508 3,891 5,153 5,037 4,959 4,049 4,104 4,217 4,776 4,063 4,186 4,116 4,540 5,055 4,217 4,329 4,893 4,671 5,123 5,148 5,593 4,703 5,161 20,605
1,335 997 1,615 1,502 1,064 1,029 1,393 559 1,677 1,590 1,783 2,018 1,802 701 928 939 1,366 731 2,197 1,558 1,732 2,234 2,711 2,689 2,230 1,714 2,453 1,943 2,104 1,952 1,535 2,584 2,288 2,531 3,497 3,774 3,639 2,813 3,365 4,086 13,903
42 40 45 52 48 51 46 45 44 48 45 123 209 279 362 357 346 355 353 330 328 323 326 313 299 294 288 282 280 316 425 521 505 496 494 485 480 432 411 407 1,730
1,559 1,086 1,955 1,295 1,183 698 1,779 517 2,167 1,505 1,979 1,776 1,349 -129 -304 1,627 2,257 -10,451 2,530 1,553 2,157 1,858 1,687 1,958 2,209 1,859 2,770 1,859 2,137 1,674 -11,516 1,286 1,676 175 2,971 1,773 3,114 1,470 3,240 4,086 11,910
344 188 429 373 327 3,027 284 135 255 347 264 337 -17 931 462 1,707 379 -424 501 492 605 -514 404 529 601 -166 503 -218 203 -88 392 -398 461 99 509 460 919 384 561 770 2,634
1,202 894 1,574 916 845 -2,328 1,486 373 1,901 1,160 1,710 1,432 1,353 -1,056 -775 -85 1,872 -10,027 2,021 1,055 1,546 2,372 1,278 1,421 1,606 2,022 2,262 2,073 1,928 1,762 -11,911 1,680 1,211 72 2,456 1,310 2,201 1,087 2,677 3,317 9,282
1,706 1,248 2,193 1,558 1,419 946 1,968 719 2,376 1,725 2,194 2,068 1,729 1,386 2,535 4,542 5,258 -7,406 5,551 4,595 5,212 4,760 4,597 4,854 5,096 4,674 5,487 4,573 4,852 4,454 -8,559 4,403 4,773 2,551 4,477 3,269 4,605 2,879 4,245 4,940 16,669

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?